GlobalData on MSN22h
Alleviant Medical wins IDE for no-implant atrial shunt device pivotal trialThe trial, which will involve around 350 patients with reduced ejection fraction, will begin enrolling in early 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback